ID
23142
Beschrijving
Responsible Party: Heidelberg University ClinicalTrials.gov Identifier: NCT02208128 History of Changes Other Study ID Numbers: S-539/2013 DRKS00006193 ( Other Identifier: Deutsches Register Klinischer Studien ) Study First Received: June 2, 2014 Last Updated: July 31, 2014 Molecular Determinants for Therapy Response on Renal Cell Carcinoma (MORE) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02208128
Link
https://clinicaltrials.gov/ct2/show/NCT02208128
Trefwoorden
Versies (1)
- 25-06-17 25-06-17 -
Geüploaded op
25 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Renal Cell Carcinoma DRKS00007604 DRKS00006193 NCT02208128 DRKS00006193
Eligibility Renal Cell Carcinoma NCT02208128 DRKS00006193
- StudyEvent: ODM
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschrijving
Mental Disorder
Datatype
boolean
Alias
- UMLS CUI [1]
- C0004936
Beschrijving
Neoplasms, Multiple Primary
Datatype
boolean
Alias
- UMLS CUI [1]
- C0027663
Beschrijving
Bleeding risk, Wound healing disorder
Datatype
boolean
Alias
- UMLS CUI [1]
- C3251812
- UMLS CUI [2]
- C1096106
Beschrijving
Informed Consent
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021430
Beschrijving
Contraindication for surgical intervention
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0543467
Similar models
Eligibility Renal Cell Carcinoma NCT02208128 DRKS00006193
- StudyEvent: ODM
C1515974 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C1096106 (UMLS CUI [2])
C0543467 (UMLS CUI [1,2])